Clinical outcome of nivolumab in older and frail patients with recurrent/metastatic head and neck squamous cell carcinoma

被引：1
|
作者：
Becherini, Carlotta [1 ]
Banini, Marco [2 ,3 ]
Desideri, Isacco [2 ]
Salvestrini, Viola [2 ]
Caprara, Luisa [2 ]
Scotti, Vieri [1 ]
Ganovelli, Michele [2 ]
Morelli, Ilaria [2 ]
Romei, Andrea [2 ]
Livi, Lorenzo [1 ,2 ]
Bonomo, Pierluigi [1 ]
机构：
[1] Azienda Osped Univ Careggi, Radiat Oncol Dept, Florence, Italy
[2] Univ Florence, Dept Biomed Expt & Clin Sci Mario Serio, Florence, Italy
[3] Univ Florence, Radiat Oncol Dept, AOU Careggi, Lgo Brambilla 3, I-50134 Florence, Italy
来源：
JOURNAL OF GERIATRIC ONCOLOGY | 2023年 / 14卷 / 01期
关键词：
Nivolumab; Older patients; Immunotherapy; Geriatric oncology; Head and neck cancer; CANCER; CHEMOTHERAPY; MANAGEMENT; CETUXIMAB; RECURRENT;
D O I：
10.1016/j.jgo.2022.09.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [22] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    [J]. CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [23] Baseline Neutrophil-to-Lymphocyte Ratio and Glasgow Prognostic Score are Associated with Clinical Outcome in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab
    Chikuie, Nobuyuki
    Hamamoto, Takao
    Ueda, Tsutomu
    Taruya, Takayuki
    Kono, Takashi
    Furuie, Hiromi
    Ishino, Takashi
    Takeno, Sachio
    [J]. ACTA MEDICA OKAYAMA, 2021, 75 (03) : 335 - 343
  • [24] Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck
    Fanucchi, M
    Khuri, FR
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (06) : 809 - 815
  • [25] Association of Pretreatment Neutrophil-to- Eosinophil Ratio with Clinical Outcomes in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab
    Suzuki, Shinsuke
    Abe, Tomoe
    Endo, Tentaro
    Kaya, Haruka
    Kitabayashi, Takuro
    Kawasaki, Yohei
    Yamada, Takechiyo
    [J]. CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3293 - 3302
  • [26] Nivolumab in squamous cell carcinoma of the head and neck
    Specenier, Pol
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (05) : 409 - 420
  • [27] Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in Older Patients: Are New Agents Bringing New Hope?
    Rocca, Maria Cossu
    Lorini, Luigi
    Szturz, Petr
    Bossi, Paolo
    Vermorken, Jan B.
    [J]. DRUGS & AGING, 2023, 40 (02) : 135 - 143
  • [28] Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in Older Patients: Are New Agents Bringing New Hope?
    Maria Cossu Rocca
    Luigi Lorini
    Petr Szturz
    Paolo Bossi
    Jan B. Vermorken
    [J]. Drugs & Aging, 2023, 40 : 135 - 143
  • [29] Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck
    Hanna, Glenn J.
    O'Neill, Anne
    Shin, Kee-Young
    Wong, Kristine
    Jo, Vickie Y.
    Quinn, Charles T.
    Cutler, Jennifer M.
    Flynn, Michelle
    Lizotte, Patrick H.
    Annino, Donald J., Jr.
    Goguen, Laura A.
    Kass, Jason, I
    Rettig, Eleni M.
    Sethi, Rosh K., V
    Lorch, Jochen H.
    Schoenfeld, Jonathan D.
    Margalit, Danielle N.
    Tishler, Roy B.
    Everett, Peter C.
    Desai, Anupam M.
    Cavanaugh, Megan E.
    Paweletz, Cloud P.
    Egloff, Ann Marie
    Uppaluri, Ravindra
    Haddad, Robert, I
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (03) : 468 - 478
  • [30] Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Wada, Akihisa
    Enokida, Tomohiro
    Okano, Susumu
    Sato, Masanobu
    Tanaka, Hideki
    Ueda, Yuri
    Fujisawa, Takao
    Takeshita, Naohiro
    Tanaka, Nobukazu
    Tahara, Makoto
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 184 : 30 - 38
12345